Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

IGF-1 LR3 — laboratory reference

IGF-1 LR3 — laboratory reference When qualified laboratories evaluate UK peptides for B2B supply, documentation scope matters as much as catalogue identity: COA and SDS ship with released lots, and third-party testing is included only when explicitly released for that batch. IGF-1 LR3 is supplied as lyophilised laboratory reference material for qualified in-vitro and analytical research with batch documentation. Key facts SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder Intended laboratory context Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings Specifications Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

IGF-1 LR3 — laboratory reference

When qualified laboratories evaluate UK peptides for B2B supply, documentation scope matters as much as catalogue identity: COA and SDS ship with released lots, and third-party testing is included only when explicitly released for that batch.

IGF-1 LR3 is supplied as lyophilised laboratory reference material for qualified in-vitro and analytical research with batch documentation.

Key facts

SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder

Intended laboratory context

Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings

Specifications

Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description)

Documentation and batch release

COA and SDS are supplied with released lots within the scope described on this page. Independent third-party reports are provided only when released for a specific lot.

Storage and handling

Store lyophilised material frozen (typically -20 °C) unless SDS states otherwise Protect from moisture and light; minimise freeze–thaw cycles

Solubility and reconstitution

Follow SDS and SOP. Laboratory-grade sterile or bacteriostatic water may be used where appropriate for documented preparation steps.

Related materials

Bacteriostatic water for laboratory preparation | Long R3 laboratory reference

FAQs What documentation ships with orders?

COA and SDS for released lots, within the analytical scope described on this page. Is third-party testing on every batch?

No. Some lots ship with in-house or supplier release records only; third-party reports when released for that lot. Who is supply intended for?

Qualified UK laboratories and research organisations. How should storage be managed after reconstitution?

Follow your SOP and the SDS for stability, container choice, and holding time.

Research use only — not for human or veterinary use

For qualified laboratory and in-vitro use only. Sold as non-clinical reference material; purchasers are responsible for lawful use, handling, and disposal per the SDS and applicable requirements.

Connected topics

Follow this recovery question